Koninklijke Philips N.V. (PHG)
China is attractive 'long term,' says Philips CEO
Roy Jakobs, CEO of Philips, discusses earnings and his business outlook.
Philips issues its second straight profit warning on China. The stock is hammered, again.
Philips shares fell sharply on Wednesday as the Dutch healthcare equipment maker again warned on China and again triggered a big drop in its stock price.
Philips sees 2025 comparable sales growth between 1%-3%
Dutch healthcare technology company Philips forecast 2025 comparable sales growth between 1% and 3% on Wednesday after missing market expectations for the final quarter of last year partly due to a double-digit decline in China.
Philips 66: Refining Hurts Q4, But Long-Term Value Remains
Phillips 66 shares have underperformed due to weak refining margins, but I remain bullish given the company's diversified business and cost rationalization efforts. Despite a Q4 loss, PSX's midstream segment showed strength, and the acquisition of EPIC NGL should boost future EBITDA. The company plans to return 50% of operating cash flow to investors and aims for $15 billion mid-cycle EBITDA by 2027.
Philips sells small chipmaking subsidiary, Telegraaf reports
Healthcare technology company Philips has sold its Xiver computer chip subsidiary, the Telegraaf newspaper reported, citing Xiver's CEO.
Philips is focused on a 'resilient and agile' supply chain: CEO
Philips (PHG) CEO Roy Jakobs sits down with Catalysts Hosts Seana Smith and Madison Mills to discuss the health tech company's strategy for President-elect Donald Trump's second term in the White House. "We have, of course, been going through several supply chain challenges [since the pandemic].
Philips CEO on AI in health care: We're 'very passionate' about giving time back to the caregivers
Roy Jakobs, Royal Philips CEO, joins 'Squawk Box' to discuss the use of AI in health care, whether the technology can provide better patient care, cost structure for hospitals for implement AI, and more.
Philips Q3 Earnings Beat: Will Weak Outlook Drag the Stock Down?
PHG's third-quarter results reflect improved earnings but highlight challenges with declining sales in China and growth in other regions, showcasing mixed performance.
Philips Stock Crashes On China Slump
Philips' Q3 earnings showed flat sales but improved margins, driven by better productivity and pricing, despite weak performance in China. Risks include significant exposure to the Chinese market and competition, while opportunities lie in cost-cutting, AI implementation, and global growth. Due to China's economic weakness, Philips revised its sales growth guidance down to 0.5-1.5%, affecting stock performance and future expectations.
Down -18.64% in 4 Weeks, Here's Why Philips (PHG) Looks Ripe for a Turnaround
Philips (PHG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.
Philips: Looking Undervalued After Q3 Earnings Drop
Philips faces challenges in China, but its overall fundamentals remain strong, with significant growth potential in other markets and segments like cardiovascular and ultrasound. Despite a 17% share price drop, Philips is undervalued at €24.20/share, presenting a compelling investment opportunity with an expected 11% annual EPS growth. The company shows margin improvements and resilience in various segments, indicating effective price hikes and operational adjustments amidst market uncertainties.
